- Language: English
- 615 Pages
- Published: November 2011
- Region: Global
Global Biobanking Market 2011-2015
- Published: August 2012
- Region: Global
- 40 pages
TechNavio's analysts forecast the Global Biobanking market to grow at a CAGR of 5.5 percent over the period 2011-2015. One of the key factors contributing to this market growth is the significant increasing prevalence of chronic diseases. The Global Biobanking market has also been witnessing the trend of an increasing number of mergers and acquisitions among vendors. However, the lack of standardized and high-quality human biospecimens could pose a challenge to the growth of this market.
TechNavio's report, the Global Biobanking Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Biobanking market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include Thermo Fischer Scientific Inc., Beckman Coulter Inc., Tecan AG, and New Brunswick Scientific Co. Inc.
Other vendors mentioned in the report: Sanyo Biomedical, Nexus Biosystems Inc., Starlims Corp., Asterand plc, Cryo-Cell International Inc., GenVault Corp., Labvantage Solutions Inc., Dataworks Development Inc., Vivakor Inc., Labware Inc., Biostorage technologies Inc., Qiagen NV, LifeBank USA, CBR Systems, and TAP Biosystems.
Key questions answered in this report:
What will the market size be in 2015 and at what rate will it grow?
What key trends is this market subject to?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the opportunities and threats faced by each of these key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.
TechNavio Announces the Publication of its Report - Global Biobanking Market 2011-2015
TechNavio today launched its report Global Biobanking Market 2011-2015 based on an in-depth study covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers' understanding of the present and future landscape of the market.
Commenting on the report, an analyst from TechNavio's Healthcare team said; ''The Global Biobanking market is nowadays witnessing an increased number of mergers and acquisitions among its vendors. Also, there has been an increase in collaboration of public and private sector banks. For instance, Thermo Fischer Scientific acquired Dionex Corp. in May 2011 to increase the depth of its business in innovative technologies and emerging markets. This acquisition will expand the company's presence in applied markets such as Water Testing, Environmental Analysis, and Food Safety and will increase its business in the APAC region.''
According to the report, globally, there has been an increase in the incidence of infections as well as various diseases such as cardiovascular disease (CVD), cancer, neurological diseases, respiratory diseases, and diabetes. This is because of a variety of factors such as unhealthy dietary habits, lack of physical activity, excessive consumption of alcohol, and excessive smoking. Furthermore, the rapidly expanding elderly population is increasing the number of people prone to diseases. Thus, the increasing prevalence of disease leads to the demand for various drugs used to treat them. Therefore, various pharmaceutical and biotech companies are using biobanks and their repositories to develop novel drugs for the treatment of various chronic diseases.
Further, the report also discusses that the lack of standardized and high-quality biospecimens is hampering the growth of this market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key players. SHOW LESS READ MORE >
01. Executive Summary
03. Market Coverage
04. Market Landscape
Biobanking Value Chain Framework
Five Forces Analysis
05. Geographical Segmentation
06. Key Leading Countries
07. Vendor Landscape
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Key Vendor Analysis
14.1 Thermo Fischer Scientific Inc.
14.2 Beckman Coulter Inc.
14.3 Tecan AG
14.4 New Brunswick Scientific Company Inc.
15. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Biobanking Market 2011-2015 (US$ billion)
Exhibit 2: Global Biobanking Market Segmentation
Exhibit 3: Global Biobanking Market Segmentation 2011
Exhibit 4: Global Biobanking Market 2011-2015 (percent)
Exhibit 5: Global Biobanking Market 2011-2015 (in US$ billion)
Exhibit 6: Global Biobanking Market by Geographical Segmentation 2011
Thermo Fischer Scientific, Beckman Coulter, Tecan AG, New Brunswick Scientific